Skip to main content
Clinical Trials/NCT03084978
NCT03084978
Withdrawn
Not Applicable

Randomized Prospective Study in Transcatheter Aortic Valve Replacement Patients- Conscious Sedation VS. General Anesthesia Examining the Effect on Operative Time

Montefiore Medical Center0 sitesApril 2017
ConditionsAortic Stenosis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Aortic Stenosis
Sponsor
Montefiore Medical Center
Primary Endpoint
Time-on-table
Status
Withdrawn
Last Updated
6 years ago

Overview

Brief Summary

This is a randomized controlled trial investigating the effect of general anesthesia versus conscious sedation on operative times in patients undergoing transcatheter aortic valve replacement.

Registry
clinicaltrials.gov
Start Date
April 2017
End Date
April 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Signed informed consent, signed Health Insurance Portability and Accountability Act (HIPAA) documentation)
  • Age over 18 years of age.
  • Women of child bearing age must have a negative urine or serum pregnancy test.
  • Clinical indication for a transfemoral aortic valve replacement.
  • English or Spanish speaking
  • No evidence of neurological impairment as defined by a NIHSS ≤ 1 and modified Rankin scale (mRS) ≤ 2 within 7 days prior to randomization.

Exclusion Criteria

  • Diagnosis of severe obstructive sleep apnea based on previous polysomnography, with severe defined as an apnea-hypopnea index (AHI) \>30 episodes/hr.
  • High risk for aspiration such as severe esophageal disease (e.g. achalasia, gastroparesis, etc).
  • Inability to lie supine for more than 30 minutes.
  • Marginal femoral vessels with concern for possible conversion to transapical or transaortic access.
  • Patient refusal
  • Patient involved in another research study
  • Psychiatric condition precluding ability to provide informed consent
  • History of clinical stroke within 3 months prior to randomization

Outcomes

Primary Outcomes

Time-on-table

Time Frame: <1 day

* time to patient on table to surgical drapes down * time to patient on table to when deemed safe for transport by anesthesiologist and surgeon

Secondary Outcomes

  • Number of patients with serious adverse events(within 30 days)
  • Length of stay(within 30 days)
  • Readmissions(within 30 days)
  • Number of Patients with Valve Complications(within 30 days)
  • Contrast usage(<1 day)
  • Fluoroscopy time(<1 day)

Similar Trials